Eupraxia OTC Stock Buy Hold or Sell Recommendation

EPRXF -  USA Stock  

USD 2.30  0.00  0.00%

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Eupraxia Pharmaceuticals is 'Strong Hold'. Macroaxis provides Eupraxia Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EPRXF positions. The advice algorithm takes into account all of Eupraxia Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.

Eupraxia Advice 

The advice is provided from Eupraxia Pharmaceuticals' buy-and-hold perspective. Continue to Eupraxia Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Eupraxia and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Eupraxia Pharmaceuticals.

Execute Eupraxia Pharmaceuticals Buy or Sell Advice

The Eupraxia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Eupraxia Pharmaceuticals. Macroaxis does not own or have any residual interests in Eupraxia Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Eupraxia Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Eupraxia PharmaceuticalsBuy Eupraxia Pharmaceuticals
Strong Hold


Not too volatileDetails

Hype Condition


Current Valuation

Fairly ValuedDetails

Odds of Distress

Above AverageDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

For the selected time horizon Eupraxia Pharmaceuticals has a Risk Adjusted Performance of 0.132, Jensen Alpha of 0.0854, Total Risk Alpha of 0.0776 and Treynor Ratio of 0.782
We provide trade advice to complement the prevailing expert consensus on Eupraxia Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. Use Eupraxia Pharmaceuticals ebitda, debt to equity, as well as the relationship between the Debt to Equity and market capitalization to ensure your buy or sell decision on Eupraxia Pharmaceuticals is adequate. Please also check Eupraxia Pharmaceuticals cash per share to verify your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Eupraxia Pharmaceuticals Trading Alerts and Improvement Suggestions

Eupraxia Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (19.41 M).
Eupraxia Pharmaceuticals has accumulated about 33.67 M in cash with (11.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 13.0% of the company shares are held by company insiders
Latest headline from Eupraxia Pharmaceuticals to Present at H.C. Wainwright BIOCONNECT Virtual Conference - Yahoo Finance

Eupraxia Pharmaceuticals Returns Distribution Density

The distribution of Eupraxia Pharmaceuticals' historical returns is an attempt to chart the future uncertainty of Eupraxia Pharmaceuticals' future price movements. The chart of the probability distribution of Eupraxia Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Eupraxia Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Eupraxia Pharmaceuticals returns is essential to provide solid investment advice for Eupraxia Pharmaceuticals stock.
Mean Return0.1Value At Risk0.00
Potential Upside0.00Standard Deviation0.58
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Eupraxia Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Eupraxia Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Eupraxia Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Eupraxia Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Eupraxia stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW0.11
Overall volatility
Information ratio 0.13

Eupraxia Pharmaceuticals Volatility Alert

Eupraxia Pharmaceuticals exhibits very low volatility with skewness of 6.34 and kurtosis of 41.56. However, we advise investors to further study Eupraxia Pharmaceuticals technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Eupraxia Pharmaceuticals' otc stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Eupraxia Pharmaceuticals' otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Eupraxia Pharmaceuticals Implied Volatility

Eupraxia Pharmaceuticals' implied volatility exposes the market's sentiment of Eupraxia Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Eupraxia Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Eupraxia Pharmaceuticals stock will not fluctuate a lot when Eupraxia Pharmaceuticals' options are near their expiration.

Eupraxia Pharmaceuticals Fundamentals Vs Peers

Comparing Eupraxia Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Eupraxia Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Eupraxia Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Eupraxia Pharmaceuticals or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Eupraxia Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Eupraxia Pharmaceuticals by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Eupraxia Pharmaceuticals to competition
FundamentalsEupraxia PharmaceuticalsPeer Average
Return On Asset(52.08) %(0.14) %
Current Valuation7.7 M16.62 B
Shares Outstanding14.24 M571.82 M
Shares Owned by Insiders13.45 %10.09 %
Shares Owned by Institutions4.43 %39.21 %
Price to Book1.39 X9.51 X
EBITDA(14.9 M)3.9 B
Net Income(19.41 M)570.98 M
Cash and Equivalents33.67 M2.7 B
Cash per Share2.36 X5.01 X
Total Debt9.38 M5.32 B
Debt to Equity0.41 %48.70 %
Current Ratio12.03 X2.16 X
Book Value Per Share1.66 X1.93 K
Cash Flow from Operations(11.2 M)971.22 M
Earnings Per Share(1.49) X3.12 X
Market Capitalization32.76 M19.03 B
Z Score1.88.72

About Eupraxia Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Eupraxia Pharmaceuticals? Buying financial instruments such as Eupraxia OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Eupraxia Pharmaceuticals investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Eupraxia Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Restaurants Hotels Motels Thematic Idea Now

Restaurants Hotels Motels
Restaurants Hotels Motels Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Restaurants Hotels Motels theme has 61 constituents.
View All  Next Launch Restaurants Hotels Motels
Continue to Eupraxia Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Eupraxia Pharmaceuticals information on this page should be used as a complementary analysis to other Eupraxia Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Eupraxia OTC Stock analysis

When running Eupraxia Pharmaceuticals price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Eupraxia Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eupraxia Pharmaceuticals. If investors know Eupraxia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eupraxia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Eupraxia Pharmaceuticals is measured differently than its book value, which is the value of Eupraxia that is recorded on the company's balance sheet. Investors also form their own opinion of Eupraxia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eupraxia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eupraxia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eupraxia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eupraxia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Eupraxia Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eupraxia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.